细胞系开发血清市场基于(关键区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00015863
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2023 年细胞系开发血清市场规模估计为 11.6 亿美元,预计到 2031 年将达到 20 亿美元;预计到 2031 年复合年增长率为 7.0%。采用新技术进行细胞系开发可能仍是细胞系开发血清市场的关键趋势。

细胞系开发血清市场分析

药物开发的进步、政府对疫苗开发的举措、生物技术和制药公司研发活动的增加、个性化医疗需求的增加以及生物制药需求的增加,推动了病毒抗原市场的增长。全球慢性病和传染病的流行率不断上升,需要新的治疗方法,这也推动了细胞系开发血清市场的增长

细胞系开发血清市场概况

细胞系是一种已建立的细胞培养物,其中细胞在生长培养基中繁殖,并在具有生长空间的地方繁殖。不同的细胞系由其他细胞制成。细胞系开发血清市场的增长主要归因于血清作为细胞在基础培养基中培养的生长和粘附因子、激素、脂质和矿物质的来源。血清还调节细胞膜通透性,并作为酶、脂质、微量营养素和微量元素进入细胞的载体。质量和安全是细胞系开发血清市场的关键考虑因素,因为使用受污染或低质量的血清会影响细胞培养性能和产品质量。

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

细胞系开发血清市场:

Cell Line Development Serum Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

细胞系开发血清市场驱动因素和机遇

增加疫苗产量

慢性病和传染病的发病率不断上升,推动了全球对疫苗生产的需求。由于细胞系开发在疫苗开发和药物发现过程中起着至关重要的作用,预计市场在预测期内将出现显著增长。目前,主要的制药和生物技术公司正致力于建立先进的研究设施,以促进疫苗开发进程。为了提高疫苗的效果,细胞系的使用越来越多,这推动了对细胞系开发的需求,进而推动了细胞系开发血清市场的增长。

提高对再生医学的认识——细胞系开发血清市场的机会

过去几年,组织工程行业发展迅猛,并已发展成为再生医学的更广泛领域。再生医学专注于利用细胞工程开发修复、维护、替换和增强生物功能的临床疗法。细胞系开发是再生医学中不可或缺的重要部分。干细胞在再生医学研究中起着至关重要的作用,再生医学研究围绕着各种类型的干细胞的使用,如成体干细胞、胚胎干细胞、诱导多能细胞。细胞系用于药物的测试和开发、细胞疗法以及与癌症组织相关的研究。制药公司开发的新型再生医学干细胞上进行了安全有效的测试,以检查所开发药物的潜力及其毒性水平。因此,再生医学的进步预计将推动对用于细胞系开发的血清的需求。

细胞系开发血清市场报告细分分析

有助于得出细胞系发育血清市场分析的关键部分是类型和应用。

  • 根据类型,细胞系发育血清市场细分为胎牛血清、成年牛血清、猪血清、马血清等。胎牛血清部分在 2023 年占据最大的市场份额。
  • 根据应用,市场细分为生物生产、药物发现、组织工程和再生医学、毒性测试和学术研究。生物生产领域在 2023 年占据了最大的市场份额。

细胞系开发血清市场份额分析(按地区)

细胞系发育血清市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导着细胞系开发血清市场。在北美,美国占据着细胞系开发血清市场的很大份额。北美的增长特点是制药和生物技术公司创新产品产量的增加、该地区主要市场参与者的存在以及学术和研究机构进行的广泛研发。此外,对精准医疗发展中先进方法的日益关注以及政府和其他组织对基因组研究的大量资金进一步刺激了北美细胞系开发血清市场的增长。

 

细胞系开发血清市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响细胞系开发血清市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的细胞系开发血清市场细分和地理位置。

Cell Line Development Serum Market
  • 获取细胞系开发血清市场的区域特定数据

细胞系开发血清市场报告范围

报告属性细节
2022 年市场规模11.6亿美元
2031 年市场规模20亿美元
全球复合年增长率(2023 - 2031)7.0%
史料2021-2023
预测期2024-2031
涵盖的领域按类型
  • 胎牛血清
  • 成年牛血清
  • 猪血清
  • 马血清
  • 其他动物血清
按应用
  • 生物生产
  • 药物研发
  • 组织工程与再生医学
  • 毒性测试
  • 学术研究
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 赛默飞世尔科技公司
  • 默克集团
  • Cytiva (丹纳赫)
  • 通用电气医疗
  • 龙沙集团
  • HiMedia 实验室
  • 赛多利斯
  • 潘氏生物科技
  • 康宁公司
  • 欧洲细胞培养物保藏中心(ECACC)

 

细胞系开发血清市场参与者密度:了解其对业务动态的影响

细胞系开发血清市场正在快速增长,这得益于最终用户需求的不断增长,而这些需求是由于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素所致。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在细胞系开发血清市场运营的主要公司有:

  1. 赛默飞世尔科技公司
  2. 默克集团
  3. Cytiva (丹纳赫)
  4. 通用电气医疗
  5. 龙沙集团
  6. HiMedia 实验室

免责声明上面列出的公司没有按照任何特定顺序排列。


Cell Line Development Serum Market

 

  • 了解细胞系开发血清市场顶级关键参与者概览

细胞系开发血清市场新闻和最新发展

细胞系开发血清市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是病毒抗原和策略市场发展的列表:

  • BioIVT 推出了人类 AB 血清产品线,以补充细胞培养基并促进细胞和基因治疗的发展。BioIVT 提供从健康男性 AB 血型捐献者身上采集的血浆和凝血血清。所有产品均经过无菌、过滤,可用于细胞培养。(来源:BioIVT,公司网站,2021 年)
  • 2024 年 2 月,Gemini Bioproducts LLC 面向细胞治疗和再生医学市场推出了一款新型人类 AB 血清产品 GemCellTM Plus Xeno Free。(来源:Biospace,新闻稿,2024 年)

细胞系开发血清市场报告覆盖范围和交付成果

“细胞系开发血清市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内涵盖的所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • Cytiva (Danaher)
  • GE Healthcare
  • Lonza Group
  • HiMedia Laboratories
  • Sartorius
  • PAN Biotech
  • Corning Incorporated
  • European Collection of Cell Cultures (ECACC) 
  • Bovogen Biologicals Pty Ltd.
  • WuXi AppTec
  • American Type Culture Collection (ATCC)

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.